# A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products

> **NCT00875277** · PHASE2 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 24 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** LEO 29102 cream
- **DRUG:** LEO 29102 Cream Vehicle
- **DRUG:** Betamethasone Dipropionate Cream
- **DRUG:** LEO 29102 Plus Calcipotriol Cream
- **DRUG:** LEO 29102 Plus Betamethasone Dipropionate
- **DRUG:** Daivobet® Ointment

## Key facts

- **NCT ID:** NCT00875277
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00875277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00875277, "A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00875277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*